Literature DB >> 9414289

Molecular delineation of 13q deletion boundaries in 20 patients with myeloid malignancies.

R La Starza1, I Wlodarska, A Aventin, D Falzetti, B Crescenzi, M F Martelli, H Van den Berghe, C Mecucci.   

Abstract

Fluorescent in situ hybridization (FISH) analysis with a panel of DNA probes for 13q13.1-q14.3 was performed on 20 cases of myeloid malignancies, of which 17 showed a del(13)(q) and three had translocations affecting 13q. By chromosome morphology, deletions consistently involved bands q14 and q21. In addition to confirming the chromosome data, FISH allowed us to delineate a commonly deleted region that was flanked by YAC 833A2 and YAC 854D4. Three cases with 13q translocations unexpectedly showed accompanying cryptic microdeletions of 13q, and in one case the commonly deleted region could be narrowed to a genomic segment, which includes YAC 937C7, RB1, and YAC 745E3. Homozygous deletions were not detected. This region overlaps with the smallest deleted region of 13q14 in chronic lymphocytic leukemia.

Entities:  

Mesh:

Year:  1998        PMID: 9414289

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

Review 1.  Molecular pathogenesis of MDS.

Authors:  Hisamaru Hirai
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

2.  Evaluation of 13q14 status in patients with chronic lymphocytic leukemia using single nucleotide polymorphism-based techniques.

Authors:  Katy Hanlon; Sian Ellard; Claudius E Rudin; Susan Thorne; Teresa Davies; Lorna W Harries
Journal:  J Mol Diagn       Date:  2009-05-21       Impact factor: 5.568

Review 3.  Risk definition and management strategies in retinoblastoma: current perspectives.

Authors:  Fariba Ghassemi; Alireza Khodabande
Journal:  Clin Ophthalmol       Date:  2015-06-08

Review 4.  RNF6 as an Oncogene and Potential Therapeutic Target-A Review.

Authors:  Paweł Zapolnik; Antoni Pyrkosz
Journal:  BioTech (Basel)       Date:  2020-11-11

5.  Investigating the targets of MIR-15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLL).

Authors:  Katy Hanlon; Claudius E Rudin; Lorna W Harries
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

6.  ARL11 regulates lipopolysaccharide-stimulated macrophage activation by promoting mitogen-activated protein kinase (MAPK) signaling.

Authors:  Subhash B Arya; Gaurav Kumar; Harmeet Kaur; Amandeep Kaur; Amit Tuli
Journal:  J Biol Chem       Date:  2018-04-04       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.